# Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain

> **NCT01415895** · PHASE2 · COMPLETED · sponsor: **Annette C. Toledano MD** · enrollment: 78 (actual)

## Conditions studied

- Back Pain
- Lower Back Pain
- Cervical Pain

## Interventions

- **DRUG:** Naltrexone and Clonidine Combination
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01415895
- **Lead sponsor:** Annette C. Toledano MD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01415895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01415895, "Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01415895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*